Contributing Member of the Healthcare Councils
Names and details of certain GLG News authors are available only to GLG Clients and Council Members. GLG News authors are subject-matter experts within the GLG Councils and are available for expert consulting - by phone, in-person, or written analysis. To find out how to become a GLG client or Council Member, click here.
GLG News by this Author
GLG News is now G+ Insights
-
G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.
-
Provenge should not be covered by Medicare
July 3, 2011
Medicare to Cover Drug for Prostate Cancer | online.wsj.com
Medicare will be bankrupt by the time I turn 65. Like it or not, we MUST institute rationing of expensive care, and that includes drugs. The cost per day of life benefit of Provenge is about $2,000 a day, and all patients treated with it die. It is insane for an insolvent country to pay for this drug for it's citizens.
-
This Could Be A Real Blockbuster
October 4, 2007
An Old Antibiotic Could Reduce Stroke Damage | blogs.wsj.com
- current therapy is ineffective for most stroke victims - this study showed significant improvement in patients given minocycline with 24 hours of stroke - if larger studies confirm this, minocycline will become the standard of care
-
Finally! Rationality Returns To Psychiatric Treatment
October 4, 2007
Dual Approach Aids Depression Treatment | online.wsj.com
- this study found that a combination of antidepressant medication and psychotherapy worked better than either treatment alone in depressed adolescents - psychotherapy has almost disappeared in recent decades, in large part due to low or no reimbursement by health insurance companies
-
Screening is a Waste of Time and Money Unless There is Treatment
October 4, 2007
Screening: Testing Early for Cholesterol | www.nytimes.com
- study from BMJ suggests screening 15 month old toddlers for hypercholesterolemia - the problem is, there is no treatment for 15 month old toddlers with hypercholesterolemia
-
COX-2's are Dead In The U.S.A.
October 3, 2007
Prexige(R) receives ''not approvable'' letter in the US despite being one of the most studied COX-2 inhibitors | www.pipelinereview.com
- American physicians were lied to about the dangerous effects of COX-2 inhibitors - the F.D.A. was caught flat footed and suffered enormous loss of prestige - don't expect any new COX-2 inhibitors to be approved, or embraced by American physicians soon
-
September 28, 2007
Relieva Exceeds Expectations In Recent Clinical Trial For Eczema (Atopic Dermatitis) | www.medicalnewstoday.com
- this study of a new drug is junk science - it proves nothing, it is a phony advertisement for the medicine
-
I Think A Black Box Warning Will Come Soon
September 28, 2007
FDA Warns About Misuse Of Fentora Cancer Pain Drug | www.medicalnewstoday.com
- Fentora is a very powerful, very fast-acting drug - if not used under strict criteria, it can, and has, killed patients - I suspect it will soon come with a black box warning, holding down sales
-
September 25, 2007
NXY-059 Ineffective in Acute Ischemic Stroke: SAINT II Published | www.medscape.com
- acute stroke treament drugs are far less promising than acute myocardial treatment drugs - once again, a drug that looked promising in animal trials - NXY-059, has been proven completely useless in humans
-
Competing With Gardasil Will Be a Tough Job
September 25, 2007
Glaxo prepares to launch Cervarix after EU okay | www.reuters.com
- Glaxo is late to the table - studies to prove ANY advantage over Gardasil are only in the beginning stages
-
I Would Hold Off Until Clinical Studies Have Been Done
September 24, 2007
Feel Pudgy? There’s a Shot for That | www.nytimes.com
- Lipodissolve involves giving multiple injections of a non-F.D.A. approved, not-proven-in-clinical-trials "secret cocktail" which is claimed to dissolve fat - I would wait until clinical trials, which are in the planning stages, have been done, as there are suggestions of serious side effects
-
September 24, 2007
Shorter Treatment Time For Tuberculosis Using New Antibiotic Drug Combo | www.medicalnewstoday.com
- moxifloxacin hasn't had great success, as up to now it has been another "me-too" drug - this study shows it shortens the time needed to cure tuberculosis by one third, and saves money to boot - I predict this will become the standard treatment for TB, increasing sales of moxifloxacin
-
September 24, 2007
FDA Okays FluMist Vaccine For Young Children | www.medicalnewstoday.com
- flumist will prove attractive to parents of young children, because young children are the group most traumatized by injections
-
September 19, 2007
Painkiller Widely Abused in South | www.washingtonpost.com
- comments have been made suggesting this article is alarmist - I present two examples from my life that show why it is not
-
September 18, 2007
Sanofi aims to show there's still life in Acomplia | www.reuters.com
- Accomplia has been PROVEN to cause depression and suicidal ideation - no matter what studies Sanofi Aventis does, it will not be approved by the F.D.A.
-
Eventually, This Drug Will Be Banned
September 18, 2007
FDA approves SOMA 250 mg | www.pipelinereview.com
- Soma is highly addictive - it has no proven benefit - there are many non-addictive drugs which do what Soma claims to do
-
Favorable Safety Data on New Anti-Obesity Drug
September 13, 2007
Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review | www.medicalnewstoday.com
- this drug, Locaserin, targets obesity by a novel mechanism - this study shows no heart valve damage - what killed Phen-Phen - it could be very promising
-
A Quack Company is Caught By The FDA
September 10, 2007
FDA Issues Warning Letter To Melanocorp, Inc. For Illegal Sale Of Melanotan II -Agency Warns Consumers About Using And Purchasing Unapproved Product | www.medicalnewstoday.com
- skin cancer can be serious and even lethal - this company sold an untested an unapproved drug they claimed would prevent skin cancer - the FDA caught them
-
Ultrashape is VERY Innovative, and Looks Very Promising
September 10, 2007
Plastic And Reconstructive Surgery Publishes Clinical Trial Results Of Ultrashape(TM) Non Invasive Body Contouring System | www.medicalnewstoday.com
- ultrashape is a new process which kills fat cells by ultrasound - it provides body contouring with no anesthesia, in one office visit - it has a great potential for success
-
September 7, 2007
Merck 'good' cholesterol drug meets trial goals | www.therapeuticsdaily.com
Current therapy for increasing HDL ("good cholesterol") is limited by side effects - this drug increases HDL without the side effects - could be a blockbuster
-
Keep Your Eye On This Drug, But it is Not Clinically Proven Yet
September 7, 2007
Novartis's Tekturna shows promise in heart failure | www.reuters.com
- drug is designed to treat congestive heart failure - BNP (basal naturietic protein) is a serum marker for heart failure (CHF) - this new drug has been proven to lower BNP but NOT proven to improve CHF
- Subscribe to Updates
-
This author consults with leading institutions through GLG
Most Popular Healthcare News
-
February 7, 2012
-
What do the cloud, collaboration and virtualization have in common?
January 27, 2012
-
Clinical diagnostic acquisitions dominate 2011 top ten list
January 12, 2012
-
Gene therapy success threatens drugs for hemophilia and rare diseases
December 13, 2011
-
Medtech M&A activity accelerates in 2011
November 30, 2011
Gerson Lehrman Group, Inc. connects communities with knowledge through two distinct, yet complementary offerings: GLG Research and G+.